Hernandez Puts Lilly's Half Price Insulin in Perspective

March 10, 2019

"There's no justification for why prices should keep increasing at an average rate of 10 percent every year," CP3 Associate Director Dr. Inma Hernandez told NPR about rising insulin prices. The NPR piece provided background on insulin prices and put into perspective Eli Lilly's recent announcement that it will release a generic version of Humalog that will cost half as much as the name brand.